Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Health

Castle Hills 3D Orthodontics Announces New Hybrid-Responsive Website

Leave a comment


Castle Hills 3D Orthodontics in Lewisville, TX

Castle Hills 3D Orthodontics in Lewisville, TX


LEWISVILLE, Texas (PRWEB)

Castle Hills 3D Orthodontics, a provider of advanced orthodontics and dentofacial orthopedics in Lewisville, TX, is proud to announce its brand new Hybrid-Responsive™ website at https://www.castlehills3dortho.com.

With an interface that prioritizes user experience, patients will find the new Castle Hills 3D Orthodontics website informative and simple to navigate. The site is designed to be equally responsive on desktops, laptops, tablets, and smartphones, making it easy for patients to get the information they need, whether they’re at home, at work, or on-the-go.

The new website has helpful descriptions of its services, important information for patients, biographies of Dr. Seifelnasr and her team, and even new patient forms that can be printed and filled out prior to a patient’s first visit.

“At Castle Hills 3D Orthodontics, we provide orthodontic treatment to patients of all ages. The treatment plans we offer are always simple and efficient to make the journey to a beautiful smile enjoyable. We use new technologies as a tool to create space without using expanders or removing teeth. Straight teeth without extractions, results in a broader dental arch with increased mid-face support and a full broad smile. This more youthful appearance naturally benefits our patients’ self-confidence,” says Dr. Seifelnasr.

About the Dr. Amal Seifelnasr

A native of Cairo, Dr. Seifelnasr began her orthodontic career in Egypt and continued it in the United States after receiving a Master’s degree in Public Health from the University of Texas Health Science Center. She founded Castle Hills 3D Orthodontics in 2019, where she has put her passion for the science of orthodontics and a keen eye for detail to use in treating countless patients. Her goal is to ensure that each patient she sees leaves her office with the confidence to smile proudly.

About Castle Hills 3D Orthodontics

Castle Hills 3D Orthodontics is a leading orthodontic and dentofacial orthopedics practice in Lewisville, TX. From early orthodontic treatment to airway orthodontics and cleft lip and palate treatment, Castle Hills 3D Orthodontics uses the latest state-of-the-art technologies and orthodontic techniques to provide its patients with the best possible care.

To learn more or request an appointment, call 469-598-1700, visit the new website at https://www.castlehills3dortho.com, or stop by its office at 1600 FM 544, Suite #300 Lewisville, TX 75056.

Share article on social media or email:

Industry: Healthcare

MobilDrTech to Launch Low-Cost Telemedicine Exam Cam / ENT Kit for RNK Products

Leave a comment


Finally, a telemedicine tool that gets the job done and won’t break the bank!


HOUSTON (PRWEB)

MobilDrTech, Inc. is pleased to have been selected by RNK Products, Inc. (RNK), a pioneer in telemedicine stethoscopes and medical devices, to launch their new exam camera kit which breaks the barrier for value in a price sensitive market. Now there is a camera that providers can economically deploy across their programs.

Those in the market for telemedicine exam cameras, know that the market has, until now, priced out many providers due to the high price of available devices. Now there is a product that can be affordably used at virtually every telemedicine site. RNK has designed special components and software that can be used with off-the-shelf HD webcams to create a low cost, high quality exam cam with ENT (ear, nose, throat) capabilities.

MobilDrTech will offer parts kits for customers who want DIY components and a fully finished plug-and-play Exam Camera that is ready for clinic use right out of the box. The pricing is extremely attractive. MobilDrTech will offer a Logitech C920 Camera with Light Ring Kit for $178 and a kit that also includes the Otoscope Speculum for $277. Fully finished USB Exam Cams are available at only $249 for the base camera and $348 for the Exam Cam with the optional otoscope speculum. (See RExCam Kits Datasheet attached)

The RExCam Kit includes a software app (SDK is also available) that enables critical camera control, plus two custom designed hardware elements:

  • A custom designed Light Ring attaches to the webcam so it can operate independently of ambient lighting. In addition to enhanced viewing of wounds and dermatology sites, the Light Ring enables clear, sharp viewing of the throat.

  • A custom designed optics enhanced Speculum is inserted into the center of the Light Ring to enable viewing into the ear canal or nostril. The custom Speculum accepts off-the-shelf disposable speculum tips.


For over 10 years, MobilDrTech has been providing industry leading telemedicine equipment and helping customers find high quality, cost-effective solutions for their clinical services. We are privileged to be working with RNK and look forward to bringing the RExCam Kit and derivative products to market.

MobilDrTech will be selling the RExCam Kit from its’ online store at http://www.telemedicinesupply.com and to customers directly in U.S. and international markets. Kits and cameras are available immediately and will ship free via Fedex 2-day.

About MobilDrTech, Inc.: MobilDrTech is a full-service telemedicine systems and equipment supplier. Founded in 2009 and based in Houston, TX, MobilDrTech is a Value-Added Reseller (VAR) for leading telemedicine equipment manufacturers. https://mobildrtech.com

Share article on social media or email:

Health

K-Fish introduces premium seafood from Korea with “K-SEAFOOD GLOBAL WEEKS”

Leave a comment


News Image

K-SEAFOOD GLOBAL WEEKS


NEW YORK (PRWEB)

The launch in 2017 of the Korean Fishery’s national brand, K-FISH, aimed to promote the quality of Korean seafood and enhance its global competitiveness. Each year since then, the Korean fishery office has held two-week-long promotions entitled, “K-Seafood Global Weeks” in many countries. These special events are currently running in the US, Russia, and Indonesia at the same time.

This event showcased the 14 seafood products available for export, which are Gim(Laver), Miyok(Sea mustard), Oysters, Abalone, Sea cucumbers, Fish cake, Red snow crab, Seasoned squid, Conger eel, Flat fish, Tunas, Baby calms, Roes and Mackerel. The attendees were offered samples and learned of the quality of Korean seafood.

Food Bazaar, a supermarket chain that has 25 locations throughout the northeast, is hosting the K-FISH tasting events. These events introduce the K-FISH brand and stress the clean ecological environment for its production, their strict brand usage guidelines, and its rigorous quality management.

These tasting events are open to public.

About K-FISH

K-FISH is the famous Korean fishery export national brand that offers premium seafood for global seafood lovers. Based on the clean seas, the advanced management, and the stringent tests, K-FISH’s products are of the best quality and very safe. Now you can purchase their wonderful seafood in US markets. Every product is a precious gift from the pure ocean and matches their meticulous procedures.

All delicious seafood is from K-FISH!

Share article on social media or email:

Industry: Healthcare

Background Screening Firm, Cisive, Named a Top 10 HR Tech Solution Provider by MyTechMag

Leave a comment


Background Screening Firm, Cisive, Named a Top 10 HR Tech Solution Provider by MyTechMag

Cisive’s commitment to providing unparalleled insight and the most accurate information ensures that our clients overcome employment background check challenges and bring the most qualified candidates on board.


HOLTSVILLE, N.Y. (PRWEB)

Cisive, a global provider of compliance-driven human capital management and risk management solutions, recently announced it was named to MyTechMag’s Top 10 HR Tech Solution Providers for 2019. This annual listing recognizes the 10 companies that are at the forefront of providing HR Tech solutions and transforming businesses. Cisive’s suite of solutions address the human capital challenges and program needs of large enterprises in the financial services, transportation, and telecom/media markets, among others.

“It’s an honor to be recognized as a leading HR technology provider,” said Jim Owens, Cisive’s President and CEO. “Cisive’s commitment to providing unparalleled insight and the most accurate information ensures that our clients overcome employment background check challenges and bring the most qualified candidates on board.”

Cisive aims to mitigate risk for large enterprises by empowering clients with actionable intelligence and clarity throughout the hiring process. The uniqueness of Cisive’s pre-employment screening services stems from their focus on truthful reporting, legal compliance and integrity of source material.

About Cisive

Cisive is a global provider of compliance-driven human capital management and risk management solutions. The company’s core onboarding and pre-employment background screening offering provides clients with a streamlined, high quality, and regulatory compliant solution. Comprehensive services include background screening, vendor/contractor screening, executive screening, drug testing, fingerprinting, paperless onboarding and electronic Form I-9/E-Verify solutions

Cisive is accredited by the Professional Background Screening Association (PBSA) and was named for the second consecutive year by HRO Today to the 2018 Baker’s Dozen Customer Satisfaction rankings of Top Pre-Employment Screening Providers. Cisive caters to the complex challenges and program needs of large enterprises, and their dedicated, in-country account management teams uphold a strong commitment to customer satisfaction. The company serves clients in financial services, transportation, telecom/media, utilities and the home services end-markets, among others, and offers transportation clients a comprehensive, industry-focused solution through its Driver iQ brand.

Share article on social media or email:

Health

Report About Charters Being a “Rising Tide” Sinks Under Weight of Flawed Data

Leave a comment



BOULDER, Colo. (PRWEB)

A recent report from the Thomas B. Fordham Institute examines whether average achievement in a school district increases as the “market share” of charter schools rises. The report argues that there is a positive competition effect.

Yongmei Ni of the University of Utah reviewed Rising Tide: Charter School Market Share and Student Achievement, and determined that its findings have limited use in guiding policy and practice, because of the flawed data and methods it employs.

Using a national data set of school districts with longitudinal records (allowing an analysis of each school district’s changes over time), the report found that overall, higher charter market share is associated with statistically significant increases in average reading achievement (but not math achievement). Further, the report finds some positive relationships for specific racial subgroups in districts of certain sizes and geographic locations. The report concludes that charter schools are “a rising tide” that “lifts all education boats.”

Professor Ni explains that these findings and conclusions should be interpreted with extreme caution because of major weaknesses surrounding the data and methods, including the measure of charter market share, the sample selection criteria, and the overreliance on results based on a small number of districts, especially those districts with over 95th percentile of charter market share.

Overall, she concludes, the findings have little use to policymakers because of these issues with data and methods, and because the report does not probe beneath the surface. For example, it does not examine possible policy factors that might be associated with charter market share in a given area having a positive or negative association with public school systems. Similarly, it does not consider which practices might benefit charter schools and/or public school systems as a whole.

Find the review, by Yongmei Ni, at:

http://nepc.colorado.edu/thinktank/rising-tide

Find Rising Tide: Charter School Market Share and Student Achievement, written by David Griffith and published by the Fordham Institute, at:

https://fordhaminstitute.org/national/research/rising-tide-charter-market-share

NEPC Reviews (http://thinktankreview.org) provide the public, policymakers, and the press with timely, academically sound reviews of selected publications. NEPC Reviews are made possible in part by support provided by the Great Lakes Center for Education Research and Practice: http://www.greatlakescenter.org

The National Education Policy Center (NEPC), a university research center housed at the University of Colorado Boulder School of Education, produces and disseminates high-quality, peer-reviewed research to inform education policy discussions. Visit us at: https://nepc.colorado.edu

Share article on social media or email:

Industry: Healthcare

Latest Regulatory Developments and Best Practices Webinar, Dec. 2, 2019

Leave a comment


WCG_FDANews_Logo

WCG_FDANews_Logo


FALLS CHURCH, Va. (PRWEB)

Understanding the Drug Supply Chain Security Act (DSCSA)

Latest Regulatory Developments and Best Practices

An FDAnews Webinar

Monday, Dec. 2, 2019, 1:30-3:00 p.m. EST

https://www.fdanews.com/understanding-the-dscsa

Need to comply with the Drug Supply Chain Security Act’s (DSCSA) implementation requirements? Is the company clear on nuances of the guidelines regulating the drug supply chain?

Don’t miss this webinar, including:

  • Key requirements under DSCSA

  • Reporting licensure

  • Knowing how to handle suspect and illegitimate products

  • Confirming authorized trading partners

  • How to comply with important guidances including FDA’s guidance on how to exchange product tracing information (DSCSA Standards for the Interoperable Exchange of Information for Tracing of Certain Human, Finished, Prescription Drugs: How to Exchange Product Tracing Information)

  • Who exactly is regulated under DSCSA, such as repackagers, wholesale distributors, dispensers and third-party logistics providers

  • What the most complicated and nuanced requirements are under DSCSA, such as product serialization and exchange of transaction information, transaction history and transaction statement

  • Which areas will be regulated soon under DSCSA, such as requirements for dispensers and distributors

  • How FDA is enforcing DSCSA, recent actions including warning letters


William Garvin, Esq. — a Buchanan Ingersoll & Rooney PC lawyer who assists clients daily in their interactions with FDA — will provide vital information to those involved in the manufacture, ownership, distribution or sale of prescriptions pharmaceuticals.

Gain the right tactics to avoid problems with DSCSA implementation.

Interested in registering multiple sites?

Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally

to learn about our special multisite discount.

Webinar Details:

Understanding the Drug Supply Chain Security Act (DSCSA)

Latest Regulatory Developments and Best Practices

An FDAnews Webinar

Monday, Dec. 2, 2019, 1:30-3:00 p.m. EST

https://www.fdanews.com/understanding-the-dscsa

Tuition:

$287 per site

Easy Ways to Register:

Online: https://www.fdanews.com/understanding-the-dscsa

By phone: 888-838-5578 or 703-538-7600

About FDAnews:

FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews’ print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA’s complex and ever-changing regulations.

Share article on social media or email:

Health

Advanced Periodontics and Dental Implant Center of Connecticut Calms Dental Anxiety in Monroe, CT with Soothing Sedation Dentistry

Leave a comment


The Periodontists and Team at Advanced Periodontics and Dental Implant Center of Connecticut in Monroe, CT

Advanced Periodontics and Dental Implant Center of Connecticut Offers Sedation Dentistry Monroe, CT

I would recommend this practice to anyone. Dr. Amato really put me at ease. It was the best thing I ever did.


MONROE, Conn. (PRWEB)

Drs. Richard Amato and Michael Kang work to counter dental anxiety in Monroe, CT by offering sedation dentistry at their practice. Sedation dentistry helps make oral care simpler and more painless for patients. Drs. Amato and Kang have seen and treated countless patients whose severe dental anxiety has kept them from getting the oral health care they need, but who now keep coming back thanks to the warm atmosphere and sedation options provided at this state-of-the-art practice.

“I was having issues with my gums and I was afraid. Over time, my teeth were getting loose and I put it off out of fear. I used to have a lot of anxiety about going to the dentist and would not go, resulting in these gum disease problems,” says Christopher, a patient of Dr. Amato. “I would recommend this practice to anyone. Dr. Amato really put me at ease. It was the best thing I ever did.”

Sedation dentistry is an excellent solution for patients who experience mild to severe dental anxiety or fear. The practice offers oral sedation and nitrous oxide, as well as local anesthetic to help numb areas of the mouth where treatment will occur. Once a patient is sedated, they will feel calm, at ease and relaxed, but can still respond to the doctors if need be. This helps many patients receive their dental treatments, no matter how complex or extensive the need. In many cases, with the help of oral sedation or nitrous oxide, patients can have multiple treatments completed during one appointment, reducing the number of times they will need to visit the periodontists.

To supplement their calming sedation dentistry services, Drs. Amato and Kang offer modern, minimally invasive solutions for many dental treatments. The practice offers LANAP laser dentistry for treatment of gum disease without the need for scalpels or sutures, the Pinhole® Surgical Technique (PST™) for easy treatment of gum recession and full mouth dental implants as a more permanent and comfortable solution to complete tooth loss. For treatments like LANAP and PST, often minimal to no sedation is needed. Full mouth dental implant treatment always utilizes sedation dentistry and is typically completed in just one appointment, giving patients a brand-new set of teeth the same day.

In addition to sedation dentistry and minimally invasive care, Advanced Periodontics and Dental Implant Center of Connecticut offers comprehensive care from bone grafting, to periodontal maintenance and tooth extractions. The practice strives to stay up to date on the latest dental technology and trends, offering digital x-rays and 3D scanners. The doctors and team are compassionate, patient-centered and focused on providing lasting results.

Those interested in receiving gentle, pain-free dental care in Monroe, CT and surrounding areas are encouraged to connect with Drs. Amato and Kang to learn about their sedation dentistry options Consultations can be made by calling 203-268-2000 or visiting http://www.connecticutperiodontist.com.

About the Periodontists

Founder of Advanced Periodontics and Dental Implant Center of Connecticut in Monroe, Connecticut, Dr. Richard Amato, and his associate Dr. Michael Kang, are leading periodontists and dental implant specialists who offer personalized care using advanced technology. He earned his DDS degree from Stony Brook University and his Certificate of Proficiency in Periodontics from Eastman Dental Center at the University of Rochester. Dr. Amato has placed thousands of dental implants. He is the first and most experienced provider of LANAP® laser gum disease therapy in Fairfield County, CT as well as the first periodontist in Connecticut to provide the minimally invasive gum recession treatment, the Pinhole® Surgical Technique. Dr. Kang is a board-certified Diplomate of the American Academy of Periodontology. He completed his residency in periodontology from Columbia University and has published numerous articles on implant dentistry. To learn more about Dr. Amato, Dr. Kang or the services they offer visit http://www.connecticutperiodontist.com and call 203-268-2000.

Share article on social media or email:

Industry: Healthcare

EMulate® Therapeutics Announces Multiple Presentations on the Voyager and Hælo® systems

Leave a comment



SEATTLE (PRWEB)

EMulate Therapeutics, Inc., a clinical-stage therapeutic device company developing non-invasive treatments for cancers and other serious diseases, announced it will have 5 poster presentations related to its medical devices for treating adult and pediatric brain cancers at the upcoming 24th Annual Society for Neuro-Oncology SNO Meeting in Phoenix, beginning on November 20 .

Two posters will be presented by Mike Butters, EMulate’s co-founder, at the affiliated SNO-SCIDOT Joint Conference on Therapeutic Delivery to the CNS on Wednesday, November 20 at 5-7 pm. One poster describes the ability of the magnetic field of the device to penetrate the entire brain. The other poster provides early data to demonstrate that specific signals, referred to as cognates, can elicit differential behavioral responses in live animals.

Three poster presentations at the annual SNO meeting on Saturday, 23rd November, will provide updated data on the use of the Voyager ulRFE® system for treatment of patients with recurrent and newly diagnosed glioblastoma (GBM) and of the Hælo system to treat diffuse midline glioma (DMG), including diffuse intrinsic pontine glioma (DIPG).

The EMulate Voyager and Hælo systems appear to be safe for the treatment of adult and pediatric brain cancers; no serious device-related adverse events were reported. Additionally, the data from these feasibility studies suggest the EMulate Voyager and Hælo systems have clinical utility for the treatment of brain cancers and warrant further study in pivotal studies. Copies of the posters will be available at the EMulate exhibit table #312 at the SNO Conference.

Chris Rivera, EMulate Therapeutics President and Chief Executive Officer, made the announcement stating, “This year will mark our most active involvement in presenting clinical data and scientific technology regarding our proprietary Voyager and Hælo systems.”    

Rivera added “Our novel technology has the potential to transform the way we treat cancer. With these encouraging data in hand, we will continue to develop the EMulate Voyager system for the treatment of GBM and the Hælo system for the treatment of DMG/DIPG, with the aim to expand the underlying technology to additional indications in the future.”

Most recently, EMulate announced it had entered into an exclusive agreement for the distribution in India of the company’s proprietary systems for treatment of patients with selected brain cancer indications – both recurrent and newly diagnosed GBM and DMG/DPIG. The exclusive distributor is Sayre Therapeutics (Sayre), a Bangalore, India-based company that provides access to differentiated medical solutions to patients and clinicians in emerging markets by identifying high unmet needs across the healthcare continuum. The agreement with Sayre is EMulate’s second agreement with a highly-regarded international firm, the first being with Teijin Limited for the territory of Japan for the treatment of GBM.

EMulate will once again support the Annual SNO Conference at the Benefactor Sponsor Level.

About EMulate Therapeutics

Headquartered in Seattle, EMulate Therapeutics® is a clinical-stage therapeutic device company. EMulate has invented and patented a groundbreaking technology that utilizes precisely targeted ultra-low radio frequency energy (ulRFE®) to specifically regulate metabolic pathways on the molecular and genetic levels – without chemicals, radiation or drugs – delivered via a simple-to-use non-sterile, non-invasive, non-thermal, non-ionizing investigational device. The company’s goal is to transform disease treatment on a global scale with ulRFE, which can potentially be applied to a wide range of medical conditions as well as to veterinary medicine and non-medical applications. EMulate’s initial focus is on the treatment of patients with brain cancer, who are not well served by conventional standard of care therapies, which often result in poor outcomes and devastating side effects. Pre-clinical work is focused on exploring new applications in oncology. In addition, EMulate’s Voyager system for adults with GBM and its Hӕlo pediatric system are investigational medical devices in clinical development.

Media Relations Contact:

Dennis Kroft

dkroft@emulatetx.com

201-602-8354

Share article on social media or email:

Health

Bioclinica Medical Imaging Achieves Milestone with Celebration of Primary Endpoint Data Analysis Contributions to 200 FDA Approvals

Leave a comment


News Image

“At Bioclinica, we are proud to have played a part in helping our clients assess the safety and efficacy of new treatments that improve people’s lives,” said David Herron, President & CEO of Bioclinica.


PRINCETON, N.J. (PRWEB)

Bioclinica Medical Imaging, the world leader in centralized imaging services for clinical trials, announced today that it has reached a milestone in the company’s history: the company has contributed reliable data to the primary efficacy endpoint in more than 200 regulatory submissions from biopharmaceutical clients for therapies and indications subsequently approved by the U.S. Food and Drug Administration.

“At Bioclinica, we are proud to have played a part in helping our clients assess the safety and efficacy of new treatments that improve people’s lives,” said David Herron, President & CEO of Bioclinica. “We are grateful to our scientific and project teams, and to all the patients and their families who participated in the clinical studies.”

Bioclinica provides science and technology expertise to assist the life science industry in advancing the development of medical therapies through services in Medical Imaging, Drug Safety Solutions, and Software Solutions. Bioclinica Medical Imaging provides comprehensive support across multiple therapeutic areas, with particular expertise in oncology, musculoskeletal, cardiovascular, gastrointestinal, neuroscience, endocrinology, infectious and respiratory disease.

“Every day, Bioclinica’s team of professionals works to ensure the quality and integrity of the data we process, ensuring that our clients and regulatory authorities have information they can rely upon to evaluate the safety and efficacy of investigational treatments,” said Todd Kisner, Senior Vice President, Quality Assurance & Regulatory Compliance. “We look forward to continuing to partner with the biopharmaceutical industry as the pace of innovation accelerates and the demand for high-quality image and clinical data analysis combined with regulatory expertise increases.”

About Bioclinica

Bioclinica is a global life science provider that utilizes science and technology to bring clarity to clinical trials – helping companies to develop new life-improving therapies more efficiently and safely. Successful clinical trials require the ability to see key details and uncover hidden insights, and Bioclinica’s experienced scientific, medical, and domain experts bring unmatched insight across the development lifecycle, from the initial protocol to post-approval. The company’s offerings include medical imaging and cardiac safety services; clinical adjudication; randomization and trial supply management and optimization; electronic and eSource data capture; site and patient payments and budget forecasting; pharmacovigilance and trial management. The company’s thousands of employees serve more than 500 pharmaceutical, biotechnology and device organizations – including all top 20 biopharmaceutical companies and leading CROs – through offices in North America, Europe, and Asia.

Learn more about Bioclinica at http://www.Bioclinica.com. Follow the latest company news and happenings on LinkedIn and Twitter.

Share article on social media or email:



Industry: Healthcare

Colic Calm® Launches Colic Calm Probiotic – a new product for the digestive wellness of infants

Leave a comment



SARASOTA, Fla. (PRWEB)

Colic Calm, the leading effective natural solution for infant digestive discomfort, has just announced the launch of their specially formulated five-strain probiotic with guaranteed live active cultures and 5 billion CFU per serving. Colic Calm and Colic Calm Plus have been a trusted companion for many moms with infants who struggle with colic, gas, and reflux. With the launch of the Colic Calm Probiotic, many parents may find continued relief and support of infant and child gut and digestive health.

Building a healthy microbiome is critical in the very early days to establish a healthy immune system, which not only prevents serious infections but is also thought to help prevent things like allergies, eczema, asthma, autoimmune conditions like type 1 diabetes, and even neurodevelopmental issues like autism and ADHD. The demand for safe, effective and living probiotics prompted Colic Calm to create a five-strain formulation with specific probiotics known to support digestive health. Colic Calm Probiotic comes as a one-time prep kit and includes a sachet of probiotics, a one-time use funnel, a bottle of MCT oil and a syringe.

“As leaders in infant gut health, we understand how important it is to have “good bacteria” to start your baby’s digestive system off right. We wanted to create a probiotic that had guaranteed live cultures, the most effective probiotic strains available and the highest CFU count per serving and is also free from sugar, gluten, wheat, soy, dairy and animal products,” said Keith Page, CEO of Colic Calm. “Colic Calm Probiotics are safe, gentle, and intended for everyday use.”

Since it was founded, Colic Calm has been dedicated to providing babies and parents with the highest-quality remedy for colic, gas and reflux. Now with the launch of the Colic Calm Probiotic, moms can trust they will receive the same quality and effectiveness that they’ve come to depend on with Colic Calm and Colic Calm Plus. Available nationally at Buy Buy Baby, Colic Calm Probiotic is also available online at Amazon.com, Walmart.com and ColicCalm.com with a suggested retail price of $19.95.

About Colic Calm

Colic Calm is the leader in effective natural solutions for infant digestive discomfort. From the start, Colic Calm has made it their mission to develop innovative, effective and natural wellness solutions. All products are made with the highest quality natural ingredients to empower families to be their best, and healthiest selves. Colic Calm, Colic Calm Plus and Colic Calm Probiotic provide effective relief without relying on synthetic-laden formulations.

For more information contact:

Anna Chase, Director of Marketing & Digital

US: +1 941 202 4802

E: anna@ketomi.com

Share article on social media or email: